For Persistent Lyme, Psilocybin May Have Benefits
People with persistent post-treatment Lyme disease (PTLD) may benefit from controlled clinical use of psilocybin, according to researchers at the Johns Hopkins School of Medicine. In an open-label pilot study involving 20 PTLD patients, two guided psilocybin sessions over 8 weeks led to marked reductions in PTLD symptom burdens, improvements in quality of life, and […]




